U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 816

1.
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses: An American Academy of Sleep Medicine Clinical Practice Guideline
R. Nisha Aurora, David A. Kristo, Sabin R. Bista, James A. Rowley, Rochelle S. Zak, Kenneth R. Casey, Carin I. Lamm, Sharon L. Tracy, Richard S. Rosenberg
Sleep. 2012 Aug 1; 35(8): 1039–1062. Published online 2012 Aug 1. doi: 10.5665/sleep.1988
PMCID:
PMC3397811
ArticlePubReaderPDF–1.0MCite
2.
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
Mark J. Buchfuhrer, Asim Roy, Stephanye Rodriguez, Jonathan D. Charlesworth
BMC Neurol. 2023; 23: 415. Published online 2023 Nov 21. doi: 10.1186/s12883-023-03462-6
PMCID:
PMC10662398
ArticlePubReaderPDF–1.4MCite
3.
Modification and Validation of a Diagnostic Questionnaire for Restless Legs Syndrome: Modified-Restless Legs Syndrome Diagnostic Questionnaire (m-RLS-DQ)
Rohit Kumar, Vijay Krishnan, Anindya Das, Niraj Kumar, Ravi Gupta
Ann Indian Acad Neurol. 2023 Jul-Aug; 26(4): 475–483. Published online 2023 Apr 7. doi: 10.4103/aian.aian_800_22
PMCID:
PMC10645201
ArticlePubReaderPDF–4.9MCite
4.
Evaluation of the relationship between idiopathic restless legs syndrome and serum hepcidin levels
Semra Alaçam Köksal, Sena Boncuk Ulaş, Bilgehan Atılgan Acar, Türkan Acar, Yeşim Güzey Aras, Mehmet Köroğlu
Brain Behav. 2023 Nov; 13(11): e3259. Published online 2023 Sep 19. doi: 10.1002/brb3.3259
PMCID:
PMC10636386
ArticlePubReaderPDF–314KCite
5.
Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis
Anne M. Ryschon, Khoa N. Cao, Asim Roy, Jan B. Pietzsch
Neurol Ther. 2023 Dec; 12(6): 2133–2146. Published online 2023 Oct 12. doi: 10.1007/s40120-023-00551-z
PMCID:
PMC10630268
ArticlePubReaderPDF–1.7MCite
6.
Restless legs syndrome affects sleep in de novo Parkinson’s disease patients
Jae-Myung Kim, Seong-Min Choi, Soo Hyun Cho, Byeong C. Kim
Medicine (Baltimore) 2023 Nov 3; 102(44): e35551. Published online 2023 Nov 3. doi: 10.1097/MD.0000000000035551
PMCID:
PMC10627597
ArticlePubReaderPDF–441KCite
7.
Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder
Benjamin Wipper, Michelle Pearl Cooke, John W Winkelman
Nat Sci Sleep. 2023; 15: 851–859. Published online 2023 Oct 21. doi: 10.2147/NSS.S427403
PMCID:
PMC10599248
ArticlePubReaderPDF–1012KCite
8.
Developing a Behavioral Model of Restless Legs Syndrome Utilizing Mice with Natural Variances in Ventral Midbrain Iron
Christopher J Earley, Richard P Allen, Byron C Jones, Erica L Unger
Sleep Med. Author manuscript; available in PMC 2023 Oct 25.
Published in final edited form as: Sleep Med. 2020 Jul; 71: 135–140. Published online 2020 Jan 8. doi: 10.1016/j.sleep.2019.12.007
PMCID:
PMC10598803
ArticlePubReaderPDF–773KCite
9.
Exploring the causes of augmentation in restless legs syndrome
Pengyu Zeng, Tiantian Wang, Lisan Zhang, Fang Guo
Front Neurol. 2023; 14: 1160112. Published online 2023 Sep 28. doi: 10.3389/fneur.2023.1160112
PMCID:
PMC10571710
ArticlePubReaderPDF–923KCite
10.
Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
Asim Roy, Joseph Ojile, Jerrold Kram, Jonathan Olin, Russell Rosenberg, J Douglas Hudson, Richard K Bogan, Jonathan D Charlesworth
Sleep. 2023 Oct; 46(10): zsad188. Published online 2023 Jul 13. doi: 10.1093/sleep/zsad188
PMCID:
PMC10566237
ArticlePubReaderPDF–2.9MCite
11.
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
Richard K Bogan, Asim Roy, Jerrold Kram, Joseph Ojile, Russell Rosenberg, J Douglas Hudson, H Samuel Scheuller, John W Winkelman, Jonathan D Charlesworth
Sleep. 2023 Oct; 46(10): zsad190. Published online 2023 Jul 17. doi: 10.1093/sleep/zsad190
PMCID:
PMC10566236
ArticlePubReaderPDF–4.3MCite
12.
Aripiprazole, a Novel Option in the Management of Restless Legs Syndrome (RLS) Patients with Augmentation and/or Severe RLS Symptoms: A Report of 4 Cases
Elliott Kyung Lee, Naomi Spitale, Rebecca Robillard
Nat Sci Sleep. 2023; 15: 779–784. Published online 2023 Oct 5. doi: 10.2147/NSS.S421189
PMCID:
PMC10561607
ArticlePubReaderPDF–330KCite
13.
White matter microstructure alterations in idiopathic restless legs syndrome: a study combining crossing fiber-based and tensor-based approaches
Yibo Xue, Sangma Xie, Xunheng Wang, Xugang Xi, Chunyan Liu
Front Neurosci. 2023; 17: 1240929. Published online 2023 Sep 21. doi: 10.3389/fnins.2023.1240929
PMCID:
PMC10551141
ArticlePubReaderPDF–12MCite
14.
The Prevalence, Severity, and Predictive Factors of Restless Legs Syndrome in Pregnancy
Hasan Turan, Suna Aşkın Turan, Zafer Butun, Masum Kayapınar
Cureus. 2023 Sep; 15(9): e44884. Published online 2023 Sep 8. doi: 10.7759/cureus.44884
PMCID:
PMC10485731
ArticlePubReaderPDF–326KCite
15.
The Prevalence of Restless Legs Syndrome Among Pregnant Women in Saudi Arabia
Saud Alnaaim, Fatimah Alghirash, Abdulelah Alenzi, Mohammad Owaidh Abu Zahirah, Thekra Tashari, Faisal Hakami, Rehaf Alsharif
Cureus. 2023 Aug; 15(8): e42883. Published online 2023 Aug 3. doi: 10.7759/cureus.42883
PMCID:
PMC10474523
ArticlePubReaderPDF–133KCite
16.
Further studies on the role of BTBD9 in the cerebellum, sleep-like behaviors and the restless legs syndrome
Shangru Lyu, Hong Xing, Yuning Liu, Pallavi Girdhar, Fumiaki Yokoi, Yuqing Li
Neuroscience. Author manuscript; available in PMC 2023 Nov 21.
Published in final edited form as: Neuroscience. 2022 Nov 21; 505: 78–90. Published online 2022 Oct 14. doi: 10.1016/j.neuroscience.2022.10.008
PMCID:
PMC10367443
ArticlePubReaderPDF–1.0MCite
17.
Investigation of the relationship between serum irisin level in the idiopathic restless legs syndrome: Could be a marker independent of physical activity?
Sena Boncuk Ulaş, Türkan Acar, Bilgehan Atılgan Acar, Semra Alaçam Köksal, Yeşim Güzey Aras, Aybala Neslihan Alagöz, Sıdıka Sinem Gül, Nimet Uçaroğlu Can, Mehmet Köroğlu
Brain Behav. 2023 Jul; 13(7): e3100. Published online 2023 May 28. doi: 10.1002/brb3.3100
PMCID:
PMC10338749
ArticlePubReaderPDF–348KCite
18.
Elevated Cardiovascular Disease Risk in Patients with Restless Legs Syndrome
Sabri Abuş, Yaşar Kapıcı, Selçuk Ayhan, Ali Arık
Alpha Psychiatry. 2023 May; 24(3): 95–99. Published online 2023 May 1. doi: 10.5152/alphapsychiatry.2023.221043
PMCID:
PMC10334707
ArticlePubReaderPDF–214KCite
19.
A Randomized, Open Label, Exploratory Trial Comparing Efficacy of Amantadine and Ropinirole in Restless Legs Syndrome
Govind Madhaw, Ravi Gupta, Puneet Dhamija, Niraj Kumar
Sleep Sci. 2023 Jun; 16(2): 174–182. Published online 2023 Jul 6. doi: 10.1055/s-0043-1770810
PMCID:
PMC10325843
ArticlePubReaderPDF–1.2MCite
20.
Hydrotherapy and acupressure in restless legs syndrome: A randomized, controlled, 3-armed, explorative clinical trial
Julia Kubasch, Miriam Ortiz, Sylvia Binting, Ryan King, Joanna Dietzel, Rainer Nögel, Josef Hummelsberger, Stefan N. Willich, Benno Brinkhaus, Michael Teut, Julia Siewert
Medicine (Baltimore) 2023 Jun 30; 102(26): e34046. Published online 2023 Jun 30. doi: 10.1097/MD.0000000000034046
PMCID:
PMC10313283
ArticlePubReaderPDF–1.1MCite

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center